Adamed Group attends BIO-Europe Spring 2013

About Adamed
About Adamed
Adamed in Poland
Adamed across the globe
Management Team of Adamed Pharma S.A.
Mission and values
Ethics and Compliance
Adamed for the Family
News
Adamed is a pharmaceutical and biotechnology company with almost 40 years of experience, founded on the basis of Polish scientific advances and a patent portfolio.
Products
Produkty
Prescription drugs
OTC drugs
Dietary supplements
Dermocosmetics
Medical devices
We provide patients with the highest quality medicinal products that are a response to chronic civilization diseases in several therapeutic areas.
Development and innovation
Development and innovation
Research
Development of proprietary medicines
Development of value-added medicines
Business development Startups Requests for proposals and tenders
Innovation is at the core of Adamed’s evolution. It allows us to pursue our mission by responding to the key challenges of modern medicine.
ESG
CSR
Adamed Foundation
Social programmes
Code of Ethics
Responsibility is one of our key values. It is at the core of everything we do and has earned us the trust of patients and the medical community.
Career
Career
Benefits
Development
Locations
Internships and apprenticeships
People are a priority at Adamed, and their passion and dedication has helped us grow into a successful company. Recognising the value of our staff, we are committed to providing excellent work conditions and career opportunities.
Contact

Global English

Popular searches Innovations About Adamed Business Development Adamed worldwide Researches

x

Events

19 March 2013

Employees of the Adamed Group participated in a number of workshops and discussion panels during BIO-Europe Spring. They also held numerous meetings with representatives of international pharmaceutical companies. The aim of these meetings and presentations during this event was to exchange information about the latest research findings and trends in the pharmaceutical and biotechnological industries.

A total of 2000 participants from over 1200 various international biotechnological and pharmaceutical companies, investment funds, research and development centers, and innovative companies attended BIO-Europe Spring 2013.